newsfilter
← Latest News
Earnings Call Transcripts·

Silexion Therapeutics Corp 2026 Extraordinary General Meeting - SILEXION THERAPEUTICS CORP

Ladies and gentlemen, I am Mitchell Shervan, Chief Scientific and Development Officer of Selexion Therapeutics Corporation and Chairman of this meeting. I hereby call this reconvened extraordinary general meeting of Sele

Company
SILEXION THERAPEUTICS CORP
Keywords
SILEXION THERAPEUTICS CORP